Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca D Askanase

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Women'S Dermatology|January 10, 2022
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositisVictoria P Werth, Anca D Askanase, Ingrid E Lundberg
Therapeutic Advances in Musculoskeletal Disease|August 20, 2015
Belimumab in systemic lupus erythematosus: a perspective reviewJoyce S Hui-Yuen, Xiao Q Li, Anca D Askanase
Lupus Science & Medicine|March 9, 2021
SARS-CoV-2 vaccines in patients with SLEWei Tang, Anca D Askanase, Leila Khalili, et al.
Rheumatology and Therapy|August 30, 2021
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Rheumatology and Therapy|September 30, 2020
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Arthritis and Rheumatism|October 2, 2002
Long-term followup of children with neonatal lupus and their unaffected siblingsVictor Martin, Lela A Lee, Anca D Askanase, et al.
Lupus Science & Medicine|November 5, 2020
Rheumatologists' perspective on hydroxychloroquine guidelinesJames Winebrake, Leila Khalili, Julia Weiner, et al.
Lupus Science & Medicine|May 14, 2020
Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Lupus Science & Medicine|April 3, 2023
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLEAnca D Askanase, Wei Tang, Qing Zuraw, et al.
Arthritis and Rheumatism|January 31, 2002
The presence of IgG antibodies reactive with components of the SSA/Ro-SSB/La complex in human breast milk: implications in neonatal lupusAnca D Askanase, M Eugenia Miranda-Carus, Xiaoyin Tang, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Women'S Dermatology|January 10, 2022
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositisVictoria P Werth, Anca D Askanase, Ingrid E Lundberg
Therapeutic Advances in Musculoskeletal Disease|August 20, 2015
Belimumab in systemic lupus erythematosus: a perspective reviewJoyce S Hui-Yuen, Xiao Q Li, Anca D Askanase
Lupus Science & Medicine|March 9, 2021
SARS-CoV-2 vaccines in patients with SLEWei Tang, Anca D Askanase, Leila Khalili, et al.
Rheumatology and Therapy|August 30, 2021
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Rheumatology and Therapy|September 30, 2020
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Arthritis and Rheumatism|October 2, 2002
Long-term followup of children with neonatal lupus and their unaffected siblingsVictor Martin, Lela A Lee, Anca D Askanase, et al.
Lupus Science & Medicine|November 5, 2020
Rheumatologists' perspective on hydroxychloroquine guidelinesJames Winebrake, Leila Khalili, Julia Weiner, et al.
Lupus Science & Medicine|May 14, 2020
Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Lupus Science & Medicine|April 3, 2023
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLEAnca D Askanase, Wei Tang, Qing Zuraw, et al.
Arthritis and Rheumatism|January 31, 2002
The presence of IgG antibodies reactive with components of the SSA/Ro-SSB/La complex in human breast milk: implications in neonatal lupusAnca D Askanase, M Eugenia Miranda-Carus, Xiaoyin Tang, et al.
Pageof 8